SEARCH RESULTS

329930 RESULTS

Neurodegenerative Disorders-Immunotherapy and Biomarkers

CONFERENCE 2009-05-28 00:00:00-2009-05-29 00:00:00 Rudbeck Laboratory, Uppsala, Sweden 28 May 2009 to 29 May 2009 Immunotherapy targeting abnormal protein aggregates has emerged as one of the most promising treatment strategies for neurodegenerative disorders. In a pioneer study, immunization against amyl

International Conference on Frontotemporal Dementias 2010

CONFERENCE 2010-10-06 00:00:00-2010-10-10 00:00:00 Indianapolis, Indiana, U.S.A. 06 October 2010 to 10 October 2010 The program is being designed to offer presentations of cutting-edge results relevant for research and clinical practice. In addition, there will be special sessions designed for family and

2014 Zilkha Symposium on Alzheimer’s Disease and Related Disorders

CONFERENCE COVERAGE SERIES It’s Not All About You, Neurons. Glia, Blood, Arteries Shine at Symposium Fluid Markers and Imaging Back Idea of Breached Blood-Brain Barrier In Revival of Parabiosis, Young Blood Rejuvenates Aging Microglia, Cognition Glymphatic Flow, Sleep, microRNA Are

Three’s Company: Florbetaben Approved, Excludes AD Diagnosis

RESEARCH NEWS 2014-05-02 Research News A third amyloid imaging agent has joined the ranks of those approved for clinical use. Piramal Imaging’s PET tracer florbetaben, now rechristened Neuraceq, got the nod from the European Medicines Agency on February 20, and from the U.S. Food

Do Frontoparietal Regions Shrink First in Preclinical Alzheimer’s?

RESEARCH NEWS 2014-05-02 Research News Hippocampal atrophy characterizes symptomatic Alzheimer’s disease, but a study in the April 28 JAMA Neurology makes the case that degeneration actually begins in the frontoparietal cortex. Researchers led by Niklas Mattsson at the University

Alzheimer's GWAS Hits Reflected in Monocyte Gene Expression

RESEARCH NEWS 2014-05-02 Research News Genome-wide association studies reveal whether genetic variants influence susceptibility to disease, but say nothing about how they do it. In Alzheimer's, for example, most GWAS hits fall in non-coding regions of the genome, suggesting

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE